Advertisement
Screener

LIFEVANTAGE CORP (LFVN) Auditor

LIFEVANTAGE CORP Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-08-27: Fiscal year end 2026-06-30; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Salt Lake City, Utah.
  • 2025-09-04: Fiscal year end 2025-06-30; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Salt Lake City, Utah.
  • 2024-08-28: Fiscal year end 2024-06-30; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Salt Lake City, Utah.
  • 2023-08-28: Fiscal year end 2023-06-30; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Salt Lake City, Utah.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-08-272026-06-30Deloitte & Touche LLP34Salt Lake City, UtahYes
2025-09-042025-06-30Deloitte & Touche LLP34Salt Lake City, UtahYes
2024-08-282024-06-30Deloitte & Touche LLP34Salt Lake City, UtahNo
2023-08-282023-06-30Deloitte & Touche LLP34Salt Lake City, UtahNo
2022-08-232022-06-30WSRP, LLC374Salt Lake City, UtahYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41